Diversity and Inclusion in Trials

Diversity and Inclusion in Clinical Trials: Strategies for Building Representative Research

May 13, 2025

Diversity and inclusion efforts in clinical research aim to ensure that study participants reflect the real-world populations who will ultimately use investigational therapies. Historical underrepresentation of minorities, women, older adults, rural populations, and socioeconomically disadvantaged groups has contributed to health disparities, distrust in research, and biased scientific outcomes. Increasing diversity enhances scientific validity, ethical rigor, and regulatory confidence.
Click to read the full article.

Diversity and Inclusion in Trials, Patient Recruitment and Retention

Strategies for Increasing Trial Diversity in Clinical Research

June 19, 2025

digi

Population heterogeneity impacts disease presentation, drug metabolism, efficacy, and safety profiles. Lack of representation can lead to inaccurate dosing, missed adverse events, and inequitable access to emerging therapies.
Click to read the full article.

Diversity and Inclusion in Trials, Patient Recruitment and Retention

Regulatory Requirements for Inclusive Recruitment in Clinical Trials

June 19, 2025

digi

Historically, clinical trials have failed to represent populations by age, sex, race, ethnicity, and socioeconomic background. This underrepresentation has real consequences, including adverse drug reactions, limited access to innovations, and public mistrust in healthcare research. Recognizing this, global regulators are increasingly mandating the integration of Diversity, Equity, and Inclusion (DEI) into clinical trial design and conduct.
Click to read the full article.

Diversity and Inclusion in Trials, Patient Recruitment and Retention

Designing Inclusive Eligibility Criteria for Diverse Clinical Trial Enrollment

June 20, 2025

digi

Eligibility criteria are often criticized for excluding key populations such as the elderly, women of childbearing potential, those with comorbidities, and racial or ethnic minorities. These exclusions not only compromise the external validity of a study but also limit treatment options for those populations post-approval.
Click to read the full article.

Diversity and Inclusion in Trials, Patient Recruitment and Retention

Community Engagement Strategies for Diverse Enrollment in Clinical Trials

June 20, 2025

digi

Traditional top-down recruitment models often fail to reach underrepresented populations. By contrast, community engagement leverages the influence of local institutions, trusted leaders, and grassroots channels to build trust, disseminate information, and support participation.
Click to read the full article.

Diversity and Inclusion in Trials, Patient Recruitment and Retention

Barriers Faced by Minority Populations in Clinical Trials

June 20, 2025

digi

Historical injustices in medical research—such as the Tuskegee Syphilis Study in the U.S. and forced sterilization programs—have created deep-rooted mistrust in many minority communities. This mistrust extends to the pharmaceutical industry, government agencies, and clinical trial sponsors.
Click to read the full article.

Diversity and Inclusion in Trials, Patient Recruitment and Retention

Multilingual Tools for Informed Consent in Clinical Trials

June 20, 2025

digi

When participants do not fully understand the trial procedures, risks, or benefits due to language limitations, their ability to give valid consent is compromised. This can lead to ethical breaches, protocol deviations, and challenges with GMP compliance.
Click to read the full article.

Diversity and Inclusion in Trials, Patient Recruitment and Retention

Cultural Competency in Clinical Research Staff for Inclusive Trials

June 21, 2025

digi

Cultural competency refers to the ability of individuals to understand, communicate with, and effectively interact with people across cultures. In clinical research, this includes recognizing the social, cultural, religious, and linguistic factors that influence participants’ understanding of and engagement with a study.
Click to read the full article.

Diversity and Inclusion in Trials, Patient Recruitment and Retention

FDA Guidance on Diversity in Clinical Research

June 27, 2025

digi

Clinical trial participants should reflect the populations most likely to use the treatment. Without adequate representation, sponsors risk:
Click to read the full article.

Diversity and Inclusion in Trials, Patient Recruitment and Retention

Case Studies on Improving Inclusion in Clinical Trials

June 27, 2025

digi

Challenge: A major oncology sponsor observed disproportionately low enrollment of Black patients in multiple Phase II trials, despite high disease prevalence in African American communities.
Click to read the full article.

Diversity and Inclusion in Trials, Patient Recruitment and Retention